このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Smiths Group 将来の成長

Future 基準チェック /36

Smiths Group利益と収益がそれぞれ年間18.9%と5.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に15.7% 14.3%なると予測されています。

主要情報

18.9%

収益成長率

14.3%

EPS成長率

Industrials 収益成長	10.0%
収益成長率	5.2%
将来の株主資本利益率	15.7%
アナリストカバレッジ	Good
最終更新日	28 May 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BATS-CHIXE:SMINL - アナリストの将来予測と過去の財務データ ( )GBP Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
7/31/2026	3,490	381	410	596	9
7/31/2025	3,333	341	360	551	11
7/31/2024	3,157	285	324	409	11
1/31/2024	3,047	233	278	361	N/A
10/31/2023	3,042	229	245	327	N/A
7/31/2023	3,037	225	212	293	N/A
1/31/2023	2,871	-1	121	197	N/A
10/31/2022	2,719	5	156	238	N/A
7/31/2022	2,566	11	191	279	N/A
4/30/2022	2,507	131	268	367	N/A
1/31/2022	2,448	250	345	455	N/A
10/31/2021	2,427	203	382	495	N/A
7/31/2021	2,406	156	418	535	N/A
4/30/2021	2,432	116	406	520	N/A
1/31/2021	2,458	75	394	504	N/A
10/31/2020	2,503	70	357	467	N/A
7/31/2020	2,548	65	319	429	N/A
4/30/2020	2,572	82	305	420	N/A
1/31/2020	2,595	98	291	410	N/A
10/31/2019	2,547	119	260	378	N/A
7/31/2019	2,498	140	228	346	N/A
1/31/2019	1,929	66	255	369	N/A
10/31/2018	2,129	92	277	387	N/A
7/31/2018	2,328	117	299	405	N/A
1/31/2018	3,205	372	311	413	N/A
10/31/2017	3,243	471	N/A	446	N/A
7/31/2017	3,280	570	N/A	479	N/A
1/31/2017	3,194	432	N/A	462	N/A
10/31/2016	3,072	346	N/A	410	N/A
7/31/2016	2,949	259	N/A	358	N/A
4/30/2016	2,901	274	N/A	317	N/A
1/31/2016	2,853	289	N/A	275	N/A
10/31/2015	2,875	268	N/A	271	N/A
7/31/2015	2,897	246	N/A	266	N/A
4/30/2015	2,912	236	N/A	276	N/A
1/31/2015	2,926	225	N/A	285	N/A
10/31/2014	2,939	229	N/A	271	N/A
7/31/2014	2,952	233	N/A	256	N/A
4/30/2014	3,014	261	N/A	286	N/A
1/31/2014	3,075	289	N/A	317	N/A
10/31/2013	3,092	302	N/A	335	N/A
7/31/2013	3,109	315	N/A	353	N/A

アナリストによる今後の成長予測

収入対貯蓄率: SMINLの予測収益成長率 (年間18.9% ) は貯蓄率 ( 1.8% ) を上回っています。

収益対市場: SMINLの収益 ( 18.9% ) はUK市場 ( 13.2% ) よりも速いペースで成長すると予測されています。

高成長収益: SMINLの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: SMINLの収益 ( 5.2% ) UK市場 ( 3.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: SMINLの収益 ( 5.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SMINLの自己資本利益率は、3年後には低くなると予測されています ( 15.7 %)。

Smiths Group 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Smiths Group plc Raises Revenue Guidance for the Full Year 2023

Smiths Group plc Provides Revenue Guidance for the Full Year 2022

Smiths Group plc Provides Group Revenue Guidance for 2022

Recent updates

Smiths Group plc Appoints Alister Cowan as Independent Non-Executive Director and Member of the Audit & Risk Committee, Effect from 1 July 2024

First half dividend increased to UK£0.14

First half 2024 earnings released: EPS: UK£0.32 (vs UK£0.29 in 1H 2023)

Smiths Group plc, Annual General Meeting, Nov 13, 2024

Smiths Group plc Announces Directorate Changes

Smiths Group plc Announces Directors' Change in Responsibilities

Smiths Group plc Approves Final Dividend

Smiths Group plc to Report Fiscal Year 2024 Results on Sep 24, 2024

Now 20% undervalued after recent price drop

Full year 2023 earnings released: EPS: UK£0.64 (vs UK£0.028 in FY 2022)

Smiths Group plc to Report First Half, 2024 Final Results on Mar 22, 2024

Smiths Group plc (LSE:SMIN) acquired Heating & Cooling Products, Inc. for $82 million.

Smiths Group plc Raises Revenue Guidance for the Full Year 2023

Smiths Group plc, Annual General Meeting, Nov 16, 2023

Upcoming dividend of UK£0.13 per share at 2.3% yield

First half 2023 earnings released: EPS: UK£0.29 (vs UK£0.29 in 1H 2022)

Smiths Group plc Announces Tanya Fratto Did Not Seek Re-Election as Director

High number of new directors

Smiths Group plc Provides Revenue Guidance for the Full Year 2022

High number of new directors

Smiths Group plc to Report First Half, 2023 Results on Mar 24, 2023

Upcoming dividend of UK£0.27 per share

High number of new directors

Full year 2022 earnings released: EPS: UK£0.028 (vs UK£0.39 in FY 2021)

Now 21% undervalued

Smiths Group plc Recommends final dividend, Payable on 18 November 2022

Now 22% undervalued after recent price drop

Smiths Group plc Announces Directorate Changes, Effective 1 September 2022

Now 21% undervalued after recent price drop

Smiths Group plc to Report Fiscal Year 2022 Results on Sep 23, 2022

Smiths Group plc Provides Group Revenue Guidance for 2022

Smiths Group plc Announces Executive Leadership Appointments

Now 21% undervalued after recent price drop

Upcoming dividend of UK£0.12 per share

Now 22% undervalued

ICU Medical, Inc. (NasdaqGS:ICUI) completed the acquisition of Smiths Medical, Inc. from Smiths Group plc (LSE:SMIN).

High number of new directors

Upcoming dividend of UK£0.26 per share

CFO & Director recently bought UK£99k worth of stock

Full year 2021 earnings released: EPS UK£0.39 (vs UK£0.16 in FY 2020)

ICU Medical, Inc. (NasdaqGS:ICUI) entered into an agreement to acquire Smiths Medical Division from Smiths Group plc (LSE:SMIN) for $2.5 billion.

Chief Executive & Executive Director has left the company

Upcoming dividend of UK£0.12 per share

First half 2021 earnings released: EPS UK£0.053 (vs UK£0.028 in 1H 2020)

Smiths Group plc to Report First Half, 2021 Results on Mar 26, 2021

New 90-day high: UK£15.81

Smiths Group plc Appoints Karin Hoeing to Nomination & Governance Committee

Smiths Group plc to Report Fiscal Year 2020 Results on Oct 15, 2020

Smiths Group plc Announces Bruno Angelici and Olivier Bohuon Not to Seek Re-Election at the 2020 Annual General Meeting

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘